Overview

Neostigmine and Glycopyrrolate by Iontophoresis

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis.
Phase:
PHASE3
Details
Lead Sponsor:
James J. Peters Veterans Affairs Medical Center
Treatments:
Glycopyrrolate
Iontophoresis